Overview

The focus of TAHSSL – Transforming Animal-Health Solutions and Services for Low-and middle-income countries – is to address the burdens of diseases such as African swine fever (ASF), contagious bovine pleuropneumonia (CBPP), contagious caprine pleuropneumonia (CCPP), East Coast fever (ECF), ticks and tick-borne diseases (anaplasmosis, heartwater and babesiosis) in LMIC by developing veterinary medicines and diagnostic solutions, and providing services to help fill the product development pipeline.

TAHSSL will build a one-stop shop, located at the ILRI campus in Nairobi, Kenya to conduct research activities on animal health product technologies, assess technologies and technology platforms, and establish robust animal disease models. By this means, we will generate robust proof-of-concept data to de-risk potential private sector entry into product development, registration and use. This platform will thus provide services to the public and private sector to accelerate animal health product development and facilitate market development and entry.

Objectives

• To provide high quality technologies and services to facilitate laboratory and clinical research for development of safe and effective Animal Health products for small scale livestock producers (SSPs)
• To be a “one-stop-shop” that facilitates animal Health companies to establish viable markets for animal health products in LMICs.

Further information

TAHSSL is a joint initiative between the International Livestock Research Institute (ILRI), Clinglobal, and GALVmed. Core funding for establishing TAHSSL has been provided by the Bill & Melinda Gates Foundation.